Actively Recruiting
In-Hospital Detection of Elevated Blood Pressure: Prevalence of New or Uncontrolled Hypertension and Safety of Delaying Treatment Changes in Medical In-patients
Led by Annina Vischer · Updated on 2024-09-19
800
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial studies the occurrence of new or uncontrolled high blood pressure (hypertension) after hospital discharge in patients who had elevated blood pressure during their stay in a medical ward. It aims to find out if high blood pressure measured in the hospital reflects a real ongoing condition after discharge and whether it is safe to delay changes in blood pressure treatment until after discharge and proper evaluation. Participants are randomly assigned to one of two groups: one group receives treatment based on their physician's decision during hospitalization, while the other group postpones any changes to their blood pressure medication until after a 24-hour ambulatory blood pressure measurement taken 4 weeks after leaving the hospital. This approach allows comparison between usual care and delayed treatment adjustment. During the study, participants will have blood pressure measured at baseline and will be monitored for complications related to high or low blood pressure up to 4 weeks after discharge. Researchers will assess the prevalence of ongoing hypertension, hospital readmissions, and safety of postponing treatment changes. The total monitoring period covers the hospitalization and the four weeks following discharge.
CONDITIONS
Brief Title
In-Hospital Detection of Elevated Blood Pressure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient hospitalized on the internal medicine ward for non-cardiovascular causes
- Asymptomatic elevated blood pressure readings (140-180 mmHg systolic and/or 90-110 mmHg diastolic) on at least two occasions
- Ability to understand study procedures and provide written informed consent
You will not qualify if you...
- Hospitalization for conditions worsened by uncontrolled hypertension, including cerebrovascular events, acute coronary syndrome, or acute/decompensated heart failure
- Any condition preventing ambulatory blood pressure monitoring
- Pregnant or lactating women
- Failure to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - 4 weeks after hospital discharge
Participants undergo blood pressure measurements and ambulatory blood pressure monitoring after hospital discharge to assess hypertension status.
1 visit at baseline and 1 ambulatory blood pressure monitoring session 4 weeks after hospital discharge
Duration - Until 4 weeks after hospital discharge
Participants are observed for hypertensive and hypotensive complications and re-hospitalization up to 4 weeks after hospital discharge.
Follow-up contacts as needed during 4 weeks post-discharge
Trial Site Locations
Total: 1 location
1
University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
A
Annina Vischer, M.D.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here